Prehospital delay and time to reperfusion therapy in ST elevation myocardial infarction

Linsha George1, Lakshmi Ramamoorthy1, Santhosh Satheesh2

  • 1College of Nursing, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

Insights

ST elevation myocardial infarction (STEMI) patients in South India experience significant prehospital delays. Interventions are needed to improve emergency care systems and patient education to reduce delays in reperfusion therapy.

Area of Science:

  • Cardiology
  • Public Health
  • Emergency Medicine

Background:

  • Significant delays in reperfusion therapy for ST elevation myocardial infarction (STEMI) persist despite efforts to reduce prehospital and treatment times.
  • This study investigates patient decision delay, prehospital delay, and in-hospital times (door-to-ECG, door-to-needle, door-to-primary PCI) for STEMI patients.

Purpose of the Study:

  • To identify and analyze determinants of delays in STEMI patient care.
  • To evaluate the timeliness of reperfusion therapy in a South Indian tertiary care center.

Main Methods:

  • A cross-sectional study involving 96 STEMI patients admitted to a tertiary care center in South India.
  • Data collected via patient interviews and record reviews.
  • Statistical analysis included Kolmogorov-Smirnov test, Mann-Whitney U-test, and Kruskal-Wallis test.

Main Results:

  • Median delays: 75 min (patient decision), 290 min (prehospital), 12 min (door-to-ECG), 75 min (door-to-needle), 110 min (door-to-primary PCI).
  • Factors influencing patient decision delay: alcoholism, symptom progression, home symptom relief attempts.
  • Factors influencing prehospital delay: domicile, financial issues, prior consultation, symptom onset location, symptom interpretation, transportation mode.

Conclusions:

  • Prehospital delay in STEMI patients in South India remains unacceptably high.
  • Public education and enhanced prehospital care systems are crucial.
  • Improvements in emergency department patient flow and management are needed to meet recommended reperfusion times.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...